Home
Team
science
WHY INVEST
Securities Filings
Events
News
FAQS
Video Presentation
Why Invest
Securities Filings
Events
News
FAQ's
Video Presentation
Contact
Investors
News
The Company has submitted a request for approval to conduct Phase I & II Human Trials of its Encapsulated Islet Therapy for Type1 diabetic patients.